Go Pro
NYSE:TMO

Thermo Fisher Scientific Q3 2026 Earnings Report

Thermo Fisher Scientific logo
$652.25 -22.80 (-3.38%)
Closing price 10/1/2026 03:59 PM Eastern
Extended Trading
$650.29 -1.96 (-0.30%)
As of 06:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Thermo Fisher Scientific EPS Results

Actual EPS
N/A
Consensus EPS
$6.41
Beat/Miss
N/A
One Year Ago EPS
N/A

Thermo Fisher Scientific Revenue Results

Actual Revenue
N/A
Expected Revenue
$11.95 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Thermo Fisher Scientific Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Wednesday, October 21, 2026
Conference Call Time
7:00AM ET

Conference Call Resources

Thermo Fisher Scientific Earnings Headlines

The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
See More Thermo Fisher Scientific Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Thermo Fisher Scientific? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Thermo Fisher Scientific and other key companies, straight to your email.

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE:TMO) is a global provider of laboratory products, analytical instruments, reagents, consumables, software and services. Its offerings support research, drug discovery and development, clinical diagnostics, biotechnology and pharmaceutical manufacturing, as well as environmental, industrial and other applied markets.

The company’s portfolio includes mass spectrometers, genetic analysis and sequencing systems, electron microscopes, chromatography equipment, laboratory plastics, cell culture products, antibodies, protein and molecular biology reagents, and diagnostic testing solutions. Thermo Fisher also provides contract development and manufacturing services, clinical research services, laboratory management, instrument maintenance and other support through brands that include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.

Thermo Fisher was created in 2006 through the merger of Thermo Electron and Fisher Scientific. Headquartered in Waltham, Massachusetts, the company serves customers worldwide through a broad international manufacturing, distribution and service network. Marc N. Casper has served as the company’s president and chief executive officer since 2009 and has also held leadership roles on its board.

View Thermo Fisher Scientific Profile